The IFN-β enhancer: A paradigm for understanding activation and repression of inducible gene expression

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 64, Issue , 1999, Pages 149-159

  Munshi, N ^a   Yie, J ^a   Merika, M ^a   Senger, K ^a   Lomvardas, S ^a   Agalioti, T ^a   Thanos, D ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA INTERFERON ENHANCER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENHANCEOSOME; HIGH MOBILITY GROUP A1B PROTEIN; HISTONE ACETYLTRANSFERASE; HOLOENZYME; LYMPHOID ENHANCER FACTOR 1; RNA POLYMERASE II; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DNA BINDING; DNA SEQUENCE; ENHANCER REGION; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE REPRESSION; GENE TRANSLOCATION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; ANTIBODY AFFINITY; ARTICLE; HIGH MOBILITY GROUP BOX DOMAIN; HISTONE ACETYLATION; HUMAN; INDUCIBLE GENE EXPRESSION; NONHUMAN; NUCLEOSOME; SPATIAL ORIENTATION; STEREOSPECIFICITY; VIRUS INFECTION;

EID: 0033511709     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.1999.64.149     Document Type: Conference Paper

References (49)

1. Bannister A.J. and Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384: 641.
2. Bustin M. and Reeves R. 1996. High mobility group proteins: Architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. 54: 35.
3. Carey M. 1998. The enhanceosome and transcriptional synergy. Cell 92: 5.
4. Collins T., Read M.A., Neish A.S., Whitley M.Z., Thanos D., and Maniatis T. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J. 9: 899.
5. Du W. and Maniatis T. 1994. The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms. Proc. Natl. Acad. Sci. 91: 11318.
6. Du W., Thanos D., and Maniatis T. 1993. Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements. Cell 74: 887.
7. Ernst P and Smale S.T. 1995. Combinatorial regulation of transcription I: General aspects of transcriptional control. Immunity 2:311.
8. Escalante C.R., Yie J., Thanos D., and Aggarwal A.K. 1998. Structure of 1RF-1 with bound DNA reveals determinants of interferon regulation. Nature 391: 103.
9. Falvo J.V., Thanos D., and Maniatis T. 1995. Reversal of intrinsic DNA bends in the IFN-β gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell 83: 1101.
10. Ghersa P., Whelan J., Cambet Y., DeLamarter J.G., and van Huijsduijnen R.H. 1997. Distamycin prolongs E-selectin expression by interacting with a specific NF-κB-HMG-I(Y) binding site in the promoter. Nucleic Acids Res. 25: 339.
11. Giese K., Cox J., and Grosschedl R. 1992. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 69: 185.
12. Giese K., Kingsley C., Kirshner J.R., and Grosschedl R. 1995. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. Genes Dev. 9: 995.
13. Gu W. and Roeder R.G. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595.
14. Hampsey M. and Reinberg D. 1999. RNA polymerase II as a control panel for multiple coactivator complexes. Curr. Opin. Genet. Dev. 9: 132.
15. Huth J.R., Bewley C.A., Nissen M.S., Evans J.N.S., Reeves R., Gronenborn A.M., and Clore G.M. 1997. The solution structure of an HMG-I(Y)-DNA complex defines a new architectural minor groove binding motif. Nat. Struct. Biol. 4: 657.
16. Imhof A., Yang X.-J., Ogryzko V.V., Nakatani Y., Wolffe A.P., and Ge H. 1997. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7: 689.
17. Juang Y.-T., Lowther W., Kellum M., Au W.-C., Lin R., Hiscott J., and Pitha P.M. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. 95: 9837.
18. Kadosh D. and Struhl K. 1998. Histone deacetylase activity of Rpd3 is important for transcriptional repression in vivo. Genes Dev. 12: 797.
19. Kee B.L., Arias J., and Montminy M.R. 1996. Adaptor-mediated recruitment of RNA polymerase II to a signal-dependent activator. J. Biol. Chem. 271: 2373.
20. Kim T.K. and Maniatis T. 1997. The mechanism of transcriptional synergy of an in vitro assembled interferon-β enhanceosome. Mol. Cell 1: 119.
21. Kim T.K., Kim T.H., and Maniatis T. 1998. Efficient recruitment of TFIIB and CBP-RNA polymerase II holoenzyme by an interferon-β enhanceosome in vitro. Proc. Natl. Acad. Sci. 95: 12191.
22. Kornberg R.D. and Lorch Y. 1999. Chromatin-modifying and -remodeling complexes. Curr. Opin. Genet. Dev. 9: 148.
23. Korzus E., Torchia J., Rose D.W., Xu L., Kurokawa R., McInerney E.M., Mullen T.-M., Glass C.K., and Rosenfeld M.G. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279: 703.
24. Kuo M.-H. and Allis C.D. 1998. Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20: 615.
25. Kurokawa R., Kalafus D., Ogliastro M.-H., Kioussi C., Xu L., Torchia J., Rosenfeld M.G., and Glass C.K. 1998. Differential use of CREB binding protein-coactivator complexes. Science 279: 700.
26. Luger K. and Richmond T.J. 1998. The histone tails of the nucleosome. Curr. Opin. Genet. Dev. 8: 140.
27. Maniatis T., Falvo J.V., Kim T.H., Kim T.K., Lin C.H., Parekh B.S., and Wathelet M.G. 1998. Structure and function of the interferon-β enhanceosome. Cold Spring Harbor Symp. Quant. Biol. 63: 609.
28. Maniatis T., Whittemore L.-A., Du W., Fan C.-M., Keller A.D., Palombella V.J., and Thanos D. 1992. Positive and negative regulation of human interferon-β gene transcription. In Transcriptional regulation (ed. S. McKnight and K. Yamamoto), p. 1193. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
29. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T.M., Amakawa R., Kishihara K., Wakeham A., Potter J., Furlonger C.L., Narendran A., Suzuki H., Ohashi P.S., Paige C.J., Taniguchi T., and Mak T.W. 1993. Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75: 83.
30. Merika M., Williams A.J., Chen G., Collins T., and Thanos D. 1998. Recruitment of CBP/p300 by the IFN β enhanceosome is required for synergistic activation of transcription. Mol. Cell 1: 277.
31. Munshi N., Merika M., Yie J., Senger K., Chen G., and Thanos D. 1998. Acetylation of HMG I(Y) by CBP turns off IFN β expression by disrupting the enhanceosome. Mol. Cell 2: 457.
32. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., and Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953.
33. Palombella V.J. and Maniatis T. 1992. Inducible processing of interferon regulatory factor-2. Mol. Cell. Biol. 12: 3325.
34. Parekh B.S. and Maniatis T. 1999. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-β promoter. Mol. Cell 3: 125.
35. Ptashne M. 1992. A genetic switch. Blackwell Scientific Publications and Cell Press, Cambridge, Massachusetts.
36. Puri P.L., Sartorelli V., Yang X.-J., Hamamori Y., Ogryzko V.V., Howard B.H., Kedes L., Wang J.Y.J., Graessmann A., Nakatani Y., and Levrero M. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1: 35.
37. Ren B., Chee K.J., Kim T.H., and Maniatis T. 1999. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. Genes Dev. 13: 125.
38. Sato M., Tanaka N., Hata N., Oda E., and Taniguchi T. 1998. Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-β gene. FEBS Lett. 425: 112.
39. Schafer S.L., Lin R., Moore P.A., Hiscott J., and Pitha P.M. 1998. Regulation of type I interferon gene expression by interferon regulatory factor-3. J. Biol. Chem. 273: 2714.
40. Strahl K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12: 599.
41. Thanos D. and Maniatis T. 1992. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell 71: 777.
42. _. 1995a. Identification of the rel family members required for virus induction of the human beta interferon gene. Mol. Cell. Biol. 15: 152.
43. _. 1995b. Virus induction of human IFN β gene expression requires assembly of an enhanceosome. Cell 83: 1091.
44. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., and Maniatis T. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1: 507.
45. Workman J.L. and Kingston R.E. 1998. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu. Rev. Biochem. 67: 545.
46. Yang X.J., Ogryzko V.V., Nishikawa J., Howard B.H., and Nakatani Y. 1996. A p300/CBP-associated factor that com-petes with the adenoviral oncoprotein E1a. Nature 382: 319.
47. Yie J., Liang S., Merika M., and Thanos D. 1997. Intra- and intermolecular cooperative binding of high-mobility-group protein I(Y) to the beta-interferon promoter. Mol. Cell. Biol. 17: 3649.
48. Yie J., Merika M., Munshi N., Chen G., and Thanos D. 1999. The role of HMG I(Y) in the assembly and function of the IFN-β enhanceosome. EMBO J. 18: 3074.
49. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., and Fujita T. 1998. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17: 1087.